Citadel Advisors
ULBI icon

Citadel Advisors’s Ultralife ULBI Stock Holding History

Citadel Advisors’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$538 – 15201
2025
Q1 		$538 Sell
100
-5,900
-98% -$40.1K ﹤0.01% 14248
2024
Q4 		$44.7K Sell
6,000
-400
-6% -$3.29K ﹤0.01% 12503
2024
Q3 		$57.9K Buy
6,400
+3,600
+129% +$37.1K ﹤0.01% 11748
2024
Q2 		$29.7K Sell
2,800
-1,000
-26% -$10.6K ﹤0.01% 12285
2024
Q1 		$33.5K Buy
3,800
+2,900
+322% +$23.6K ﹤0.01% 12582
2023
Q4 		$6.14K Sell
900
-300
-25% -$2.46K ﹤0.01% 13373
2023
Q3 		$11.7K Buy
+1,200
New +$9.62K ﹤0.01% 12995
2023
Q2 		– Sell
-1,000
Closed -$4.02K – 15273
2023
Q1 		$4.02K Sell
1,000
-400
-29% -$1.61K ﹤0.01% 13994
2022
Q4 		$5.4K Buy
+1,400
New +$6.46K ﹤0.01% 14003

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Citadel Advisors's ULBI Position: Q2 2026 in Review

Citadel Advisors reduced its Ultralife (ULBI) stake by 39% in Q2 2026, selling an estimated $108K and leaving 25,283 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #12293.

Citadel Advisors first reported a position in ULBI in Q1 2014 and has held it in 16 quarters since. The position peaked at $829K in Q3 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Citadel Advisors held 25,283 shares of Ultralife worth $160K as of Q2 2026.
  • Citadel Advisors sold 16,018 Ultralife shares in Q2 2026, an estimated $108K.
  • Ultralife made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12293 holding.
  • Citadel Advisors first reported a position in Ultralife in Q1 2014 and has held it in 16 quarters since.
  • Citadel Advisors's Ultralife position peaked at $829K in Q3 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.